Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.

Harker, James A

Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. [electronic resource] - Journal of virology Apr 2010 - 4073-82 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1098-5514

10.1128/JVI.02014-09 doi


Animals
Antibodies, Viral--blood
CD8-Positive T-Lymphocytes--immunology
Female
Interleukin-18--genetics
Killer Cells, Natural--immunology
Leukocyte Reduction Procedures
Lung--pathology
Mice
Mice, Inbred BALB C
Respiratory Syncytial Virus Infections--immunology
Respiratory Syncytial Virus Vaccines--adverse effects
Respiratory Syncytial Viruses--genetics
Vaccines, Synthetic--adverse effects
Viremia
Weight Loss